China’s Hengrui posts 89% rise in third-quarter net profit, beating estimates

Jiangsu Hengrui Pharmaceuticals, one of China’s largest drug makers, reported a 20.55 per cent rise in third-quarter revenue to 8.95 billion yuan (US$1.34 billion), beating analyst estimates of 8.55 billion yuan amid stronger innovative drug sales.